Covidien plc (COV) Reports Third-Quarter Results
8/1/2013 7:28:58 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Covidien plc (NYSE: COV) today reported results for the third quarter of fiscal 2013 (April - June 2013). Third-quarter net sales of $2.58 billion increased 3% from the $2.51 billion in the third quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points. The Pharmaceuticals business, which was spun off from Covidien on June 28, 2013, is reported in discontinued operations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by